Examining efforts to improve residents’ knowledge of documentation, coding

Standards on coding and clinical documentation are improving, but most residency programs lack education and training. In a study published in the Journal of Surgical Education, researchers evaluated residents’ current knowledge and examined the effect of an educational session on knowledge improvement.

Without the proper education, residents are unable to keep up with the changing guidelines of clinical documentation and coding. This study evaluated residents’ current knowledge and the effectiveness of an educational session in improving overall knowledge and awareness in clinical documentation and coding.

The study included 32 orthopedic residents that were all asked to complete a baseline assessment, attend a 45-minute lecture, complete a post session examination and asked to self-rate their level of comfort in coding and documentation on a scale of 1-5.

Results showed, although baseline scores were the same for junior and senior residents, a correlation between higher postgraduate level of training and higher ratings of self-perceived comfort levels. The educational session significantly improved average post session exam scores.

“The current healthcare environment necessitates better physician awareness regarding clinical documentation guidelines and coding principles,” wrote first author Matthew A. Varacallo, MD, and colleagues. “Very few adjustments to incorporate these teachings have been made to most residency training curricula, and the lack of time and resources remains the concern of many surgical programs. We have demonstrated that orthopedic resident knowledge in these important areas drastically improves after a single, high-yield 45-minute teaching session.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.